DexCom, Inc.
NasdaqGS:DXCM
Sector
Location
Market Cap
USD 34.89 B
Share Price
USD 88.99
Avg Daily Volume
3,907,873
Change (1 day)
2.59%
Change (1 year)
-17.49%
Change (YTD)
14.43%
DexCom, Inc. Cash Flow Statement 2015 - 2025
This table shows the Cash Flow Statement for DexCom, Inc. going from 2015 until 2025. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
BOE Technology Group Company Limited
USD 0.57
000725.SZ
-0.01
-0.92%
Masimo Corporation
USD 164.62
MASI
+3.24
2.01%
iRhythm Technologies, Inc.
USD 134.18
IRTC
+1.89
1.43%
Andon Health Co., Ltd.
USD 5.49
002432.SZ
-0.03
-0.52%
Intuitive Surgical, Inc.
USD 495.86
ISRG
+7.25
1.48%
Boston Scientific Corporation
USD 106.14
BSX
-0.07
-0.07%
Stryker Corporation
USD 403.53
SYK
+6.87
1.73%
Siemens Healthineers AG
USD 56.32
SHL.DE
+0.05
0.09%
Axon Enterprise, Inc.
USD 735.01
AXON
+25.75
3.63%
Edwards Lifesciences Corporation
USD 80.00
EW
+4.20
5.54%
AMETEK, Inc.
USD 180.09
AME
+0.37
0.21%
Cardinal Health, Inc.
USD 157.14
CAH
-1.14
-0.72%
GE HealthCare Technologies Inc.
USD 77.61
GEHC
+0.84
1.09%
Keysight Technologies, Inc.
USD 166.45
KEYS
+0.84
0.51%
Terumo Corporation
USD 17.52
4543.T
-0.12
-0.67%